Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia

被引:11
作者
Basile, Umberto [1 ]
Marino, Mariapaola [2 ]
Gragnani, Laura [3 ,4 ]
Napodano, Cecilia [5 ]
Gulli, Francesca [6 ]
Pocino, Krizia [5 ]
Lorini, Serena [3 ,4 ]
Santini, Stefano Angelo [1 ]
Basile, Valerio [7 ]
Miele, Luca [5 ]
Zignego, Anna Linda [3 ,4 ]
Rapaccini, Gian Ludovico [5 ]
机构
[1] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy
[2] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Ist Patol Gen, Rome, Italy
[3] AOUC, Interdept Ctr Syst Manifestn Hepatitis Viruses MA, Dept Expt & Clin Med, Florence, Italy
[4] AOUC, Dept Oncol, Florence, Italy
[5] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Med Interna & Gastroenterol, Rome, Italy
[6] Osped Madre Giuseppina Vannini, Dipartimento Med Lab, Rome, Italy
[7] Univ Tor Vergata, Dipartimento Med Lab, Rome, Italy
关键词
Hepatitis C virus; Mixed cryoglobulinemia; Free light chains; Vascular endothelial growth factor; Biomarkers; FREE LIGHT-CHAINS; ENDOTHELIAL GROWTH-FACTOR; VEGF; LYMPHOMA;
D O I
10.1016/j.jim.2019.112687
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Infections, autoimmunity and cancer play a role as determinants of etiology in Hepatitis C virus (HCV) related mixed cryoglobulinemia (MC). Several factors of risk have been suggested as markers of pathogenesis and progression of HCV-related MC into B cell Non-Hodgkin's Lymphoma (B-NHL). Here, we evaluated IgG subclass distribution, free light chains (FLCs) and vascular endothelial growth factor (VEGF) as a new combination of biomarkers. Methods: We measured IgG1-4 subclasses, FLCs and VEGF levels in sera 53 from HCV-related MC, in comparison with 40 sera from HCV negative patients with rheumatoid arthritis (RA) and 30 from healthy blood donors (HBD). Results: IgG3 levels were significantly higher in HCV-MC patients with a decrement of IgG2 and IgG4; FLC levels significantly increased in both MC and RA patients' groups; serological VEGF was higher in HCV-MC patients than in HBD in correlation with k and lambda levels. Conclusion: Our results suggest that a specific IgG subclasses pattern together with raised levels of FLCs and VEGF could represent the biomarker "signature" of an inflammation multistage of acquired immune system.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] HCV-Related immunocytoma and type II mixed cryoglobulinemia-associated autoantigens
    Simula, Maria Paola
    Caggiari, Laura
    Gloghini, Annunziata
    De Re, Valli
    AUTOIMMUNITY, PT B: NOVEL APPLICATIONS OF BASIC RESEARCH, 2007, 1110 : 121 - 130
  • [42] HLA DR-DQ combination associated with the increased risk of developing human HCV positive non-Hodgkin's lymphoma is related to the type II mixed cryoglobulinemia
    De Re, V.
    Caggiari, L.
    Monti, G.
    Libra, M.
    Spina, M.
    Dolcetti, R.
    De Zorzi, M.
    Racanelli, V.
    Crovatto, M.
    Toffoli, G.
    TISSUE ANTIGENS, 2010, 75 (02): : 127 - 135
  • [43] Paradoxical brain embolism associated with HCV-related type II mixed cryoglobulinemia
    Shibazaki, Kensaku
    Iguchi, Yasuyuki
    Kimura, Kazumi
    Wada, Kuniyasu
    Ueno, Yuji
    Sunada, Yoshihide
    JOURNAL OF CLINICAL NEUROSCIENCE, 2007, 14 (08) : 780 - 782
  • [44] CLINICAL AND VIROLOGICAL FINDINGS IN MIXED CRYOGLOBULINEMIA
    MAZZARO, C
    TULISSI, P
    MORETTI, M
    MAZZORAN, L
    PUSSINI, E
    CROVATTO, M
    SANTINI, GF
    POZZATO, G
    JOURNAL OF INTERNAL MEDICINE, 1995, 238 (02) : 153 - 160
  • [45] Central nervous system involvement in patients with HCV-related cryoglobulinemia
    Origgi, L
    Vanoli, M
    Carbone, A
    Grasso, M
    Scorza, R
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1998, 315 (03) : 208 - 210
  • [46] Interferon mono-therapy for symptomatic HCV-associated mixed cryoglobulinemia : meta-analysis of clinical studies
    Fabrizi, Fabrizio
    Dixit, Vivek
    Messa, Piergiorgio
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2013, 76 (04) : 363 - 371
  • [47] Long-Term Effect of HCV Eradication in Patients With Mixed Cryoglobulinemia: A Prospective, Controlled, Open-Label, Cohort Study
    Gragnani, Laura
    Fognani, Elisa
    Piluso, Alessia
    Boldrini, Barbara
    Urraro, Teresa
    Fabbrizzi, Alessio
    Stasi, Cristina
    Ranieri, Jessica
    Monti, Monica
    Arena, Umberto
    Iannacone, Claudio
    Laffi, Giacomo
    Zignego, Anna Linda
    HEPATOLOGY, 2015, 61 (04) : 1145 - 1153
  • [48] Predominance of type 1 (Th1) cytokine production in the liver of patients with HCV-associated mixed cryoglobulinemia vasculitis
    Saadoun, D
    Boyer, O
    Trébeden-Nègre, H
    Limal, N
    Bon-Durand, V
    Andreu, M
    Klatzmann, D
    Piette, JC
    Cacoub, P
    JOURNAL OF HEPATOLOGY, 2004, 41 (06) : 1031 - 1037
  • [49] Relationship between cryoglobulinemia-associated nephritis and HCV infection
    Roccatello, Dario
    Giachino, Osvaldo
    Menegatti, Elisa
    Baldovino, Simone
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2008, 4 (04) : 515 - 524
  • [50] Influence of age and autoimmunity on liver disease in HCV-associated type II mixed cryoglobulinemia
    De Rosa, FG
    Pucillo, LP
    Coviello, R
    Pirro, MR
    Fiaschetti, P
    Candela, M
    Gabrielli, A
    Laganà, B
    Fiorilli, M
    Casato, M
    HUMAN IMMUNOLOGY, 2002, 63 (09) : 751 - 757